234 related articles for article (PubMed ID: 31115454)
1. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
[TBL] [Abstract][Full Text] [Related]
2. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
[TBL] [Abstract][Full Text] [Related]
4. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Shamriz O; Simon AJ; Lev A; Megged O; Ledder O; Picard E; Joseph L; Molho-Pessach V; Tal Y; Millman P; Slae M; Somech R; Toker O; Berger M
Clin Exp Immunol; 2020 Jun; 200(3):215-227. PubMed ID: 32201938
[TBL] [Abstract][Full Text] [Related]
5. The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease.
Zheng HB; de la Morena MT; Suskind DL
Front Immunol; 2021; 12():675186. PubMed ID: 34122435
[TBL] [Abstract][Full Text] [Related]
6. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
[TBL] [Abstract][Full Text] [Related]
7. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
[TBL] [Abstract][Full Text] [Related]
8. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
Ouahed J; Spencer E; Kotlarz D; Shouval DS; Kowalik M; Peng K; Field M; Grushkin-Lerner L; Pai SY; Bousvaros A; Cho J; Argmann C; Schadt E; Mcgovern DPB; Mokry M; Nieuwenhuis E; Clevers H; Powrie F; Uhlig H; Klein C; Muise A; Dubinsky M; Snapper SB
Inflamm Bowel Dis; 2020 May; 26(6):820-842. PubMed ID: 31833544
[TBL] [Abstract][Full Text] [Related]
9. Higher Prevalence of Monogenic Cause Among Very Early Onset Inflammatory Bowel Disease in Children: Experience From a Tertiary Care Center From Northern India.
Poddar U; Aggarwal A; Jayalakshmi K; Sarma MS; Srivastava A; Rawat A; Yachha SK
Inflamm Bowel Dis; 2023 Oct; 29(10):1572-1578. PubMed ID: 36594920
[TBL] [Abstract][Full Text] [Related]
10. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study.
Suzuki T; Sasahara Y; Kikuchi A; Kakuta H; Kashiwabara T; Ishige T; Nakayama Y; Tanaka M; Hoshino A; Kanegane H; Abukawa D; Kure S
J Clin Immunol; 2017 Jan; 37(1):67-79. PubMed ID: 27747465
[TBL] [Abstract][Full Text] [Related]
11. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report.
Kelsen JR; Dawany N; Martinez A; Grochowski CM; Maurer K; Rappaport E; Piccoli DA; Baldassano RN; Mamula P; Sullivan KE; Devoto M
BMC Gastroenterol; 2015 Nov; 15():160. PubMed ID: 26581487
[TBL] [Abstract][Full Text] [Related]
12. Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.
Conrad MA; Kelsen JR
Pediatr Dev Pathol; 2019; 22(3):183-193. PubMed ID: 30841788
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China.
Fang YH; Luo YY; Yu JD; Lou JG; Chen J
World J Gastroenterol; 2018 Mar; 24(9):1035-1045. PubMed ID: 29531467
[TBL] [Abstract][Full Text] [Related]
14. The role of monogenic disease in children with very early onset inflammatory bowel disease.
Kelsen JR; Baldassano RN
Curr Opin Pediatr; 2017 Oct; 29(5):566-571. PubMed ID: 28700415
[TBL] [Abstract][Full Text] [Related]
15. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency.
Salzer E; Kansu A; Sic H; Májek P; Ikincioğullari A; Dogu FE; Prengemann NK; Santos-Valente E; Pickl WF; Bilic I; Ban SA; Kuloğlu Z; Demir AM; Ensari A; Colinge J; Rizzi M; Eibel H; Boztug K
J Allergy Clin Immunol; 2014 Jun; 133(6):1651-9.e12. PubMed ID: 24746753
[TBL] [Abstract][Full Text] [Related]
16. A Novel Pathogenic Variant in
Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
Front Immunol; 2020; 11():884. PubMed ID: 32625199
[TBL] [Abstract][Full Text] [Related]
17. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG; Schwerd T; Moutsianas L; Cavounidis A; Fachal L; Pandey S; Kammermeier J; Croft NM; Posovszky C; Rodrigues A; Russell RK; Barakat F; Auth MKH; Heuschkel R; Zilbauer M; Fyderek K; Braegger C; Travis SP; Satsangi J; Parkes M; Thapar N; Ferry H; Matte JC; Gilmour KC; Wedrychowicz A; Sullivan P; Moore C; Sambrook J; Ouwehand W; Roberts D; Danesh J; Baeumler TA; Fulga TA; Carrami EM; Ahmed A; Wilson R; Barrett JC; Elkadri A; Griffiths AM; ; ; ; ; ; ; Snapper SB; Shah N; Muise AM; Wilson DC; Uhlig HH; Anderson CA
Nat Commun; 2020 Feb; 11(1):995. PubMed ID: 32081864
[TBL] [Abstract][Full Text] [Related]
18. Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes.
Ashton JJ; Mossotto E; Stafford IS; Haggarty R; Coelho TAF; Batra A; Afzal NA; Mort M; Bunyan D; Beattie RM; Ennis S
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00129. PubMed ID: 32463623
[TBL] [Abstract][Full Text] [Related]
19. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
Front Immunol; 2018; 9():203. PubMed ID: 29479355
[TBL] [Abstract][Full Text] [Related]
20. Primary Immunodeficiencies Associated With Early-Onset Inflammatory Bowel Disease in Southeast and East Asia.
Sasahara Y; Uchida T; Suzuki T; Abukawa D
Front Immunol; 2021; 12():786538. PubMed ID: 35095863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
